Literature DB >> 19782040

Precision of protein aggregation measurements by sedimentation velocity analytical ultracentrifugation in biopharmaceutical applications.

John P Gabrielson1, Kelly K Arthur, Michael R Stoner, Bradley C Winn, Brent S Kendrick, Vladimir Razinkov, Juraj Svitel, Yijia Jiang, Paul J Voelker, Cledwyn A Fernandes, Ron Ridgeway.   

Abstract

Sedimentation velocity analytical ultracentrifugation (SV-AUC) is routinely applied in biopharmaceutical development to measure levels of protein aggregation in protein products. SV-AUC is free from many limitations intrinsic to size exclusion chromatography (SEC) such as mobile phase and column interaction effects on protein self-association. Despite these clear advantages, SV-AUC exhibits lower precision measurements than corresponding measurements by SEC. The precision of SV-AUC is influenced by numerous factors, including sample characteristics, cell alignment, centerpiece quality, and data analysis approaches. In this study, we evaluate the precision of SV-AUC in its current practice utilizing a multilaboratory, multiproduct intermediate precision study. We then explore experimental approaches to improve SV-AUC measurement precision, with emphasis on utilization of high quality centerpieces.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782040     DOI: 10.1016/j.ab.2009.09.036

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Quantifying Trace Amounts of Aggregates in Biopharmaceuticals Using Analytical Ultracentrifugation Sedimentation Velocity: Bayesian Analyses and F Statistics.

Authors:  Lucas Wafer; Marek Kloczewiak; Yin Luo
Journal:  AAPS J       Date:  2016-05-16       Impact factor: 4.009

Review 2.  Sedimentation velocity analytical ultracentrifugation for characterization of therapeutic antibodies.

Authors:  Susumu Uchiyama; Masanori Noda; Elena Krayukhina
Journal:  Biophys Rev       Date:  2017-12-14

Review 3.  Best Practices for Aggregate Quantitation of Antibody Therapeutics by Sedimentation Velocity Analytical Ultracentrifugation.

Authors:  George M Bou-Assaf; Ivan L Budyak; Michael Brenowitz; Eric S Day; David Hayes; John Hill; Ranajoy Majumdar; Paola Ringhieri; Peter Schuck; Jasper C Lin
Journal:  J Pharm Sci       Date:  2022-01-02       Impact factor: 3.784

Review 4.  Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.

Authors:  Steven A Berkowitz; John R Engen; Jeffrey R Mazzeo; Graham B Jones
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

5.  Calibrating analytical ultracentrifuges.

Authors:  Huaying Zhao; Ai Nguyen; Samuel C To; Peter Schuck
Journal:  Eur Biophys J       Date:  2021-01-04       Impact factor: 1.733

6.  Strategies for the assessment of protein aggregates in pharmaceutical biotech product development.

Authors:  John den Engelsman; Patrick Garidel; Ronald Smulders; Hans Koll; Bryan Smith; Stefan Bassarab; Andreas Seidl; Otmar Hainzl; Wim Jiskoot
Journal:  Pharm Res       Date:  2010-10-23       Impact factor: 4.200

7.  A multilaboratory comparison of calibration accuracy and the performance of external references in analytical ultracentrifugation.

Authors:  Huaying Zhao; Rodolfo Ghirlando; Carlos Alfonso; Fumio Arisaka; Ilan Attali; David L Bain; Marina M Bakhtina; Donald F Becker; Gregory J Bedwell; Ahmet Bekdemir; Tabot M D Besong; Catherine Birck; Chad A Brautigam; William Brennerman; Olwyn Byron; Agnieszka Bzowska; Jonathan B Chaires; Catherine T Chaton; Helmut Cölfen; Keith D Connaghan; Kimberly A Crowley; Ute Curth; Tina Daviter; William L Dean; Ana I Díez; Christine Ebel; Debra M Eckert; Leslie E Eisele; Edward Eisenstein; Patrick England; Carlos Escalante; Jeffrey A Fagan; Robert Fairman; Ron M Finn; Wolfgang Fischle; José García de la Torre; Jayesh Gor; Henning Gustafsson; Damien Hall; Stephen E Harding; José G Hernández Cifre; Andrew B Herr; Elizabeth E Howell; Richard S Isaac; Shu-Chuan Jao; Davis Jose; Soon-Jong Kim; Bashkim Kokona; Jack A Kornblatt; Dalibor Kosek; Elena Krayukhina; Daniel Krzizike; Eric A Kusznir; Hyewon Kwon; Adam Larson; Thomas M Laue; Aline Le Roy; Andrew P Leech; Hauke Lilie; Karolin Luger; Juan R Luque-Ortega; Jia Ma; Carrie A May; Ernest L Maynard; Anna Modrak-Wojcik; Yee-Foong Mok; Norbert Mücke; Luitgard Nagel-Steger; Geeta J Narlikar; Masanori Noda; Amanda Nourse; Tomas Obsil; Chad K Park; Jin-Ku Park; Peter D Pawelek; Erby E Perdue; Stephen J Perkins; Matthew A Perugini; Craig L Peterson; Martin G Peverelli; Grzegorz Piszczek; Gali Prag; Peter E Prevelige; Bertrand D E Raynal; Lenka Rezabkova; Klaus Richter; Alison E Ringel; Rose Rosenberg; Arthur J Rowe; Arne C Rufer; David J Scott; Javier G Seravalli; Alexandra S Solovyova; Renjie Song; David Staunton; Caitlin Stoddard; Katherine Stott; Holger M Strauss; Werner W Streicher; John P Sumida; Sarah G Swygert; Roman H Szczepanowski; Ingrid Tessmer; Ronald T Toth; Ashutosh Tripathy; Susumu Uchiyama; Stephan F W Uebel; Satoru Unzai; Anna Vitlin Gruber; Peter H von Hippel; Christine Wandrey; Szu-Huan Wang; Steven E Weitzel; Beata Wielgus-Kutrowska; Cynthia Wolberger; Martin Wolff; Edward Wright; Yu-Sung Wu; Jacinta M Wubben; Peter Schuck
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

8.  Analysis of antibody aggregate content at extremely high concentrations using sedimentation velocity with a novel interference optics.

Authors:  Kristian Schilling; Frank Krause
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

9.  Identification of aggregates in therapeutic formulations of recombinant full-length factor VIII products by sedimentation velocity analytical ultracentrifugation.

Authors:  J F Healey; E T Parker; P Lollar
Journal:  J Thromb Haemost       Date:  2018-01-11       Impact factor: 5.824

10.  Measuring macromolecular size distributions and interactions at high concentrations by sedimentation velocity.

Authors:  Sumit K Chaturvedi; Jia Ma; Patrick H Brown; Huaying Zhao; P Schuck
Journal:  Nat Commun       Date:  2018-10-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.